LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health, Inc. (“Valo”), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly created position of Chief Causal AI Officer. In this role, Dr. Anagnostopoulos will lead the advancement of Valo’s human causal biology platform, translating large-scale, real‐world human data into causal insights that inform drug discovery. Valo aims to improve c
Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer
